Owkin raises €225.0M Series A round

6 May 2020· Paris, France· health, biotech, ai, b2b, pure_software

The funding was used to strengthen Owkin's AI diagnostics and infrastructure for pharmaceutical research.

Investors

LeadBpifrance
Also participating
MACSF

About Owkin

Stage
Bridge
Headquarters
Paris, France
Founded
2016
Team Size
201–500
Sectors
healthbiotechaib2bpure_software

Source: https://www.nasdaqprivatemarket.com/company/owkin/